(19)
(11) EP 2 663 333 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.06.2020 Bulletin 2020/25

(45) Mention of the grant of the patent:
06.05.2020 Bulletin 2020/19

(21) Application number: 12734690.6

(22) Date of filing: 10.01.2012
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
 C07K 16/00(2006.01)
(86) International application number:
PCT/US2012/020782
(87) International publication number:
WO 2012/096960 (19.07.2012 Gazette 2012/29)

(54)

STEM CELL FACTOR INHIBITOR

STAMMZELLENFAKTORINHIBITOR

INHIBITEUR DU FACTEUR DE CELLULES SOUCHES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 10.01.2011 US 201161431246 P

(43) Date of publication of application:
20.11.2013 Bulletin 2013/47

(60) Divisional application:
20172662.7

(73) Proprietor: The Regents of The University of Michigan
Ann Arbor, Michigan 48109 (US)

(72) Inventors:
  • LUKACS, Nicholas W.
    Brighton Michigan 48116 (US)
  • DOLGACHEV, Vladislav A.
    Ann Arbor Michigan 48105 (US)
  • KUNKEL, Steven L.
    Ann Arbor Michigan 48105 (US)
  • HOGABOAM, Cory M.
    Ann Arbor Michigan 48103 (US)
  • PHAN, Sem H.
    Ann Arbor Michigan 48109 (US)

(74) Representative: Algemeen Octrooi- en Merkenbureau B.V. 
P.O. Box 645
5600 AP Eindhoven
5600 AP Eindhoven (NL)


(56) References cited: : 
US-A1- 2003 194 405
US-A1- 2005 112 698
US-A1- 2010 305 003
 US-A1- 2003 194 405
US-A1- 2007 253 951
US-B2- 7 144 731
   
  • BERLIN ET AL.: 'Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen -induced asthma.' LAB INVEST. vol. 86, no. 6, 2006, pages 557 - 65, XP055113261
  • DATABASE GENBANK 21 July 2000 'mast cell growth factor, short form precursor- human', XP055120818 Retrieved from NCBI - PROTEIN Database accession no. B61190
  • DOLGACHEV ET AL.: 'Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling.' AM J PATHOL. vol. 174, no. 2, 2009, pages 390 - 400, XP055113266
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).